Ishara Biotech Fund LP is a hedge fund based in Los Angeles, California. According to its most recent Form D, filed Jan 20, 2026, the fund has sold $8,491,000 of interests to 11 investors since its first sale in Jan 2025. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, HedgeMountain classifies it as an emerging manager. Related persons named in the filing include Shaun Mehra; Ishara Partners GP, LLC; Ishara Investments LP.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to HedgeMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $8,491,000Cumulative sales reported on Form D
- Investors
- 11
- First sale
- Jan 2, 2025
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Shaun Mehra; Ishara Partners GP, LLC; Ishara Investments LP
- Latest Form D
- Jan 20, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and HedgeMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures
Size compared with every hedge fund
Raised more than 33% of the 1,051 hedge funds based in California, and more than 19% of all 10,157 that report sales.